Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance

American Journal of Physiology - Cell Physiology

Volumn 291, Issue 4, 2006, Pages

  Vasanji, Zainisha ^b   Cantor, Elliott J F ^b   Juric, Danijel ^b   Moyen, Mellissa ^b   Netticadan, Thomas ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b NONE

Author keywords

Cardiomyopathy; Diabetes mellitus; Echocardiography

Indexed keywords

CALCIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART CONTRACTION; HEART MUSCLE CONTRACTILITY; HEART PERFORMANCE; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SARCOPLASMIC RETICULUM;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CALCIUM-BINDING PROTEINS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIABETES MELLITUS, TYPE 2; DIASTOLE; DIETARY SUCROSE; ECHOCARDIOGRAPHY; HEART; INSULIN RESISTANCE; ISOENZYMES; MALE; MYOCARDIAL CONTRACTION; PHOSPHORYLATION; PREDIABETIC STATE; RATS; RATS, SPRAGUE-DAWLEY; SARCOPLASMIC RETICULUM; SYSTOLE;

EID: 33749370815     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00086.2005     Document Type: Article

References (61)

1. Aguilera AA, Diaz GH, Barcelata ML, Guerrero OA, and Ros RM. Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-α in rats with sucrose-induced metabolic syndrome. J Nutr Biochem 15: 350-357, 2004.
2. Aligent Technologies. In: System Reference: Measurements and Calculations - Aligent SONOS 5500/4500 (4th ed.). Andover, MA: Aligent Technologies, 2000.
3. Belke DD, Swanson EA, and Dillmann WH. Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 53: 3201-3208, 2004.
4. Bers DM. Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002.
5. Bidasee KR, Nallani K, Henry B, Dincer UD, and Besch HR Jr. Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts. Mol Cell Biochem 249: 113-123, 2003.
6. Celentano A, Vaccaro O, Tammaro P, Galderisi M, Crivaro M, Oliviero M, Imperatore G, Palmieri V, Iovino V, Riccardi G, and de Divitiis O. Early abnormalities of cardiac function in non-insulin-dependent diabetes mellitus and impaired glucose tolerance. Am J Cardiol 76: 1173-1176, 1995.
7. 2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 283: H1398-H1408, 2002.
8. Cohen P, Klumpp S, and Schelling DL. An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues. FEBS Lett 250: 596-600, 1989.
9. Colledge M and Scott JD. AKAPs: from structure to function. Trends Cell Biol 9: 216-221, 1999.
10. Cosson S and Kevorkian JP. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy? Diabetes Metab 29: 455-466, 2003.
11. Davidoff AJ, Mason MM, Davidson MB, Carmody MW, Hintz KK, Wold LE, Podolin DA, and Ren J. Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments. Am J Physiol Endocrinol Metab 286: E718-E724, 2004.
12. Dent CL, Bowman AW, Scott MJ, Allen JS, Lisauskas JB, Janif M, Wickline SA, and Kovacs SJ. Echocardiographic characterization of fundamental mechanisms of abnormal diastolic filling in diabetic rats with a parameterized diastolic filling formalism. J Am Soc Echocardiogr 14: 1166-1172, 2001.
13. Di Bonito P, Cuomo S, Moio N, Sibilio G, Sabatini D, Quattrin S, and Capaldo B. Diastolic dysfunction in patients with non-insulin-dependent diabetes mellitus of short duration. Diabet Med 13: 321-324, 1996.
14. Dutta K, Carmody MW, Cala SE, and Davidoff AJ. Depressed PKA activity contributes to impaired SERCA function and is linked to the pathogenesis of glucose-induced cardiomyopathy. J Mol Cell Cardiol 34: 985-996, 2002.
15. Dutta K, Podolin DA, Davidson MB, and Davidoff AJ. Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes 50: 1186-1192, 2001.
16. El Hafidi M, Cuellar A, Ramirez J, and Banos G. Effect of sucrose addition to drinking water, that induces hypertension in the rats, on liver microsomal Δ9 and Δ5-desaturase activities. J Nutr Biochem 12: 396-403, 2001.
17. 2+-ATPase modulates cardiac contraction and relaxation. Cardiovasc Res 57: 20-27, 2003.
18. Ganguly PK, Pierce GN, Dhalla KS, and Dhalla NS. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol Endocrinol Metab 244: E528-E535, 1983.
19. Giles TD and Sander GE. Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations. Cardiol Clin 22: 553-568, 2004.
20. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. National Heart, Lung, and Blood Institute, and American Heart Association. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24: 13-18, 2004.
21. Hintz KK and Ren J. Prediabetic insulin resistance is not permissive to the development of cardiac resistance to insulin-like growth factor I in ventricular myocytes. Diabetes Res Clin Pract 55: 89-98, 2002.
22. Hintz KK, Aberle NS, and Ren J. Insulin resistance induces hyperleptinemia, cardiac contractile dysfunction but not cardiac leptin resistance in ventricular myocytes. Int J Obes Relat Metab Disord 27: 1196-1203, 2003.
23. 2+ concentrations in ventricular myocytes from rats receiving sucrose-enriched diets. Int J Diabetes Metab 12: 5-9, 2004.
24. Joffe II, Travers KE, Perreault-Micale CL, Hampton T, Katz SE, Morgan JP, and Douglas PS. Abnormal cardiac function in the streptozotocin-induced, non-insulin-dependent diabetic rat. J Am Coll Cardiol 34: 2111-2119, 1999.
25. 2+-ATPase and phospholamban protein expression. Life Sci 70: 367-379, 2001.
26. Kranias EG and Di Salvo J. A phospholamban protein phosphatase activity associated with cardiac sarcoplasmic reticulum. J Biol Chem 261: 10029-10032, 1986.
27. Kranias EG, Schwartz A, and Jungmann RA. Characterization of cyclic 3′,5′-AMP-dependent protein kinase in sarcoplasmic reticulum and cytosol of canine myocardium. Biochim Biophys Acta 709: 28-37, 1982.
28. 28a. LeRoith D, Taylor SI, and Olefsky JM (Editors). Diabetes mellitus: A Fundamental and Clinical Text. Philadelphia, PA: Lippincott Williams & Wilkins, 2004.
29. Lopaschuk GD, Katz S, and McNeill JH. The effect of alloxan- and streptozotocin-induced diabetes on calcium transport in rat and cardiac sarcoplasmic reticulum. The possible involvement of long chain acylcarnitines. Can J Physiol Pharmacol 61: 439-448, 1982.
30. MacDougall LK, Jones LR, and Cohen P. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur J Biochem 196: 725-734, 1991.
31. MacLennan DH and Kranias EG. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4: 566-577, 2003.
32. Misra T, Gilchrist JS, Russell JC, and Pierce GN. Cardiac myofibrillar and sarcoplasmic reticulum function are not depressed in insulin-resistant JCR:LA-cp rats. Am J Physiol Heart Circ Physiol 276: H1811-H1817, 1999.
33. Netticadan T, Temsah R, Osada M, and Dhalla NS. Status of Ca′/calmodulin protein kinase phosphorylation of cardiac SR proteins in ischemia-reperfusion. Am J Physiol Cell Physiol 277: C384-C391, 1999.
34. Netticadan T, Temsah RM, Kawabata K, and Dhalla NS. Sarcoplasmic reticulum Ca′/calmodulin-dependent protein kinase is altered in heart failure. Circ Res 86: 596-605, 2000.
35. Netticadan T, Temsah RM, Kent A, Elimban V, and Dhalla NS. Depressed levels of Ca′-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes 50: 2133-2138, 2001.
36. Neumann J, Eschenhagen T, Jones LR, Linck B, Schmitz W, Scholz H, and Zimmermann N. Increased expression of cardiac phosphatases in patients with end-stage heart failure. J Mol Cell Cardiol 29: 265-272, 1997.
37. Nori A, Lin PJ, Cassetti A, Villa A, Bayer KU, and Volpe P. Targeting of α-kinase-anchoring protein (αKAP) to sarcoplasmic reticulum and nuclei of skeletal muscle. Biochem J 370: 873-880, 2003.
38. Pagliassotti MJ, Prach PA, Koppenhafer TA, and Pan DA. Changes in insulin action, triglycerides, and lipid composition during sucrose feeding in rats. Am J Physiol Regul Integr Comp Physiol 271: R1319-R1326, 1996.
39. Penpargkul S, Fein F, Sonnenblick EH, and Scheuer J. Depressed cardiac sarcoplasmic reticular function from diabetic rats. J Mol Cell Cardiol 13: 303-309, 1981.
40. Pierce GN, Lockwood MK, and Eckhert CD. Cardiac contractile protein ATPase activity in a diet induced model of noninsulin dependent diabetes mellitus. Can J Cardiol 5: 117-120, 1989.
41. Podolin DA, Gayles EC, Wei Y, Thresher JS, and Pagliassotti MJ. Menhaden oil prevents but does not reverse sucrose-induced insulin resistance in rats. Am J Physiol Regul Integr Comp Physiol 274: R840-R848, 1998.
42. Pugazhenthi S, Angel JF, and Khandelwal RL. Effects of vanadate administration on the high sucrose diet-induced aberrations in normal rats. Mol Cell Biochem 122: 69-75, 1993.
43. Rastogi S, Sentex E, Elimban V, Dhalla NS, and Netticadan T. Elevated levels of protein phosphatase 1 and phosphatase 2A may contribute to cardiac dysfunction in diabetes. Biochim Biophys Acta 1638: 273-277, 2003.
44. Rodrigues B, McGrath GM, and McNeill JH. Cardiac function in spontaneously diabetic BB rats treated with low and high dose insulin. Proc West Pharmacol Soc 31: 291-292, 1988.
45. Rohman MS, Emoto N, Takeshima Y, Yokoyama M, and Matsuo M. Decreased mAKAP, ryanodine receptor, and SERCA2a gene expression in mdx hearts. Biochem Biophys Res Commun 310: 228-235, 2003.
46. Sahn DJ, DeMaria A, Kisslo J, and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978.
47. Sander GE and Giles TD. Diabetes mellitus and heart failure. Am Heart Hosp J 1: 273-280, 2003.
48. 2+ exchanger activity in the diabetic heart. Cardiovasc Res 34: 129-136, 1997.
49. Schaffer SW, Mozaffari MS, Artman M, and Wilson GL. Basis for myocardial mechanical defects associated with non-insulin-dependent diabetes. Am J Physiol Endocrinol Metab 256: E25-E30, 1989.
50. Scognamiglio R, Avogaro A, Negut C, Piccolotto R, Vigili de Kreutzenberg S, and Tiengo A. Early myocardial dysfunction in the diabetic heart: current research and clinical applications. Am J Cardiol 93: 17-20, 2004.
51. Semeniuk LM, Kryski AJ, and Severson DL. Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am J Physiol Heart Circ Physiol 283: H976-H982, 2002.
52. Steenaart NA, Ganim JR, Di Salvo J, and Kranias EG. The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme. Arch Biochem Biophys 293: 17-24, 1992.
53. Temsah RM, Netticadan T, Chapman D, Takeda S, Mochizuki S, and Dhalla NS. Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol Heart Circ Physiol 277: H584-H594, 1999.
54. Toida S, Takahashi M, Shimizu H, Sato N, Shimomura Y, and Kobayashi I. Effect of high sucrose feeding on fat accumulation in the male Wistar rat. Obes Res 4: 561-568, 1996.
55. 2+-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 51: 1166-1171, 2002.
56. Vasanji Z, Dhalla NS, and Netticadan T. Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart. Mol Cell Biochem 261: 245-249, 2004.
57. Wold LE, Dutta K, Mason MM, Ren J, Cala SE, Schwanke ML, and Davidoff AJ. Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats. J Mol Cell Cardiol 39: 297-307, 2005. First published May 3, 2005; 10.1016/j.yjmcc.2005.03.014.
58. Yang J, Drazba JA, Ferguson DG, and Bond M. A-kinase anchoring protein 100 (AKAP100) is localized in multiple subcellular compartments in the adult rat heart. J Cell Biol 142: 511-522, 1998.
59. Zhong Y, Ahmed S, Grupp IL, and Matlib MA. Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am J Physiol Heart Circ Physiol 281: H1137-H1147, 2001.
60. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, and Unger RH. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97: 1784-1789, 2000.
61. Zimmet P, Alberti KG, and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414: 782-787, 2001.